These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21710271)

  • 1. Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history.
    Marin D; Galluzzo A; Plessier A; Brancatelli G; Valla D; Vilgrain V
    Eur Radiol; 2011 Oct; 21(10):2074-82. PubMed ID: 21710271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
    Grazioli L; Morana G; Kirchin MA; Schneider G
    Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
    Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
    J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
    Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
    Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases.
    Attal P; Vilgrain V; Brancatelli G; Paradis V; Terris B; Belghiti J; Taouli B; Menu Y
    Radiology; 2003 Aug; 228(2):465-72. PubMed ID: 12819340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis.
    Hussain SM; Terkivatan T; Zondervan PE; Lanjouw E; de Rave S; Ijzermans JN; de Man RA
    Radiographics; 2004; 24(1):3-17; discussion 18-9. PubMed ID: 14730031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic focal nodular hyperplasia in children: imaging features on multi-slice computed tomography.
    Liu QY; Zhang WD; Lai DM; Ou-Yang Y; Gao M; Lin XF
    World J Gastroenterol; 2012 Dec; 18(47):7048-55. PubMed ID: 23323007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI.
    Mortelé KJ; Praet M; Van Vlierberghe H; de Hemptinne B; Zou K; Ros PR
    Abdom Imaging; 2002; 27(6):700-7. PubMed ID: 12395259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal Nodular Hyperplasia and Focal Nodular Hyperplasia-like Lesions.
    LeGout JD; Bolan CW; Bowman AW; Caserta MP; Chen FK; Cox KL; Sanyal R; Toskich BB; Lewis JT; Alexander LF
    Radiographics; 2022; 42(4):1043-1061. PubMed ID: 35687520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dynamic contrast-enhanced MR imaging and digital subtraction angiography manifestation of hepatic focal nodular hyperplasia].
    Zhou JX; Li Y; Hong GB; Luo JH; Chen YT; Xu LF; Liang BL
    Ai Zheng; 2008 Nov; 27(11):1186-9. PubMed ID: 19000451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MR imaging analysis.
    Vilgrain V; Uzan F; Brancatelli G; Federle MP; Zappa M; Menu Y
    Radiology; 2003 Oct; 229(1):75-9. PubMed ID: 12944594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
    Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
    J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules.
    Kim JW; Lee CH; Kim SB; Park BN; Park YS; Lee J; Park CM
    J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
    Grazioli L; Morana G; Kirchin MA; Caccia P; Romanini L; Bondioni MP; Procacci C; Chiesa A
    J Magn Reson Imaging; 2003 May; 17(5):593-602. PubMed ID: 12720270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
    Roux M; Pigneur F; Calderaro J; Baranes L; Chiaradia M; Tselikas L; Decaens T; Costentin C; Laurent A; Azoulay D; Mallat A; Zafrani ES; Rahmouni A; Luciani A
    J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
    Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
    Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of spectral CT imaging combined with AFP in identifying liver cancer and hepatic focal nodular hyperplasia.
    Xu R; Wang J; Huang X; Zhang Q; Xie Y; Pang L; Bai L; Zhou J
    J BUON; 2019; 24(4):1429-1434. PubMed ID: 31646787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
    Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
    Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.